Md Nasrul Hoda

Title: Md Nasrul Hoda: Innovator in Stroke Treatment

Introduction

Md Nasrul Hoda is a prominent inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of medical science, particularly in the treatment of stroke patients with comorbidities. His innovative approaches aim to improve the efficacy of existing therapies for individuals suffering from complex health conditions.

Latest Patents

Md Nasrul Hoda holds 3 patents that focus on the use of GSNO reductase inhibitors as adjunct therapies in treating cerebral thrombosis and thromboembolic strokes. His latest patents include methods for administering an inhibitor of S-nitrosoglutathione reductase (GSNOR) alongside remote ischemic conditioning (RIC). This combination aims to enhance treatment outcomes for stroke patients who also have conditions such as diabetes and hypertension. The patents emphasize that when GSNOR inhibitors are used in conjunction with intravenous tissue plasminogen activator therapy (IVT) and endovascular thrombectomy (EVT), they can be effective even after five hours post-onset of stroke.

Career Highlights

Md Nasrul Hoda is affiliated with King Abdulaziz University, where he conducts research and develops innovative medical solutions. His work is pivotal in addressing the challenges faced by stroke patients with multiple health issues. His dedication to improving patient care through research and innovation is commendable.

Collaborations

He collaborates with notable colleagues, including Syed Kashif Zaidi and Muhammad Hussain Al-Qahtani. Their combined expertise contributes to the advancement of medical treatments and enhances the research environment at King Abdulaziz University.

Conclusion

Md Nasrul Hoda is a key figure in the field of stroke treatment innovation. His patents and research efforts are paving the way for more effective therapies for patients with complex health conditions. His contributions are vital for improving patient outcomes and advancing medical science.